Different Treatments in Chronic Pain Patients.

NCT05768477 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-06-06

No results posted yet for this study

Summary

The goal of this observational study is to compare different treatment options in a chronic pain population. The main questions it aims to answer are:

* What is the effectiveness of the different therapy options in the pain center of Sint-Lucas on outcomes related to pain and disability?
* What are predictive factors for the different therapy options in the pain center of Sint-Lucas? Which factors predict improvement in pain related outcomes?

Participant data will be gathered as part of their routine care. They can be advised to 4 different treatment options:

* Consultations with the pain specialist
* Interventions by the pain specialist (infiltrations, denervations)
* Baxter therapy
* Interdisciplinary treatment

Researchers will compare patients with different dominant pain mechanisms to see which treatment are most effective for which dominant pain mechanisms.

Conditions

Interventions

OTHER

Consultation

Consultation with the pain specialist, which might entail prescription of medication of vitamins.

PROCEDURE

Interventions

Facet injections, nerve denervations, infiltrations, Qutenza, Spinal Cord Stimulation, Transcutaneous Electrical Nerve Stimulation

DRUG

Baxter therapy

Ketamine or Linisol baxter therapy

BEHAVIORAL

Interdisciplinary therapy

Interdisciplinary therapy provided by the physiotherapist, psychologist and occupational therapist.

Sponsors & Collaborators

  • University Ghent

    lead OTHER

Principal Investigators

  • Jessica Van Oosterwijck · Department of Rehabilitation Sciences, Faculty of Health Sciences, Ghent University, Belgium

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-06
Primary Completion
2026-04-30
Completion
2027-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05768477 on ClinicalTrials.gov